Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemia von Kovacsovics, Tibor J., Mims, Alice, Salama, Mohamed E., Pantin, Jeremy, Rao, Narayanam, Kosak, Ken M., Ahorukomeye, Peter, Glenn, Martha J., Deininger, Michael W.N., Boucher, Kenneth M., Bavisotto, Linda M., Gutierrez-Sanchez, Gerardo, Kennedy, Thomas P., Marcus, Stephen G., Shami, Paul J.

Volltext

Tecarfarin, a Novel Vitamin K Reductase Antagonist, Is Not Affected by CYP2C9 and CYP3A4 Inhibition Following Concomitant Administration of Fluconazole in Healthy Participants von Bavisotto, Linda M., Ellis, David J., Milner, Peter G., Combs, Daniel L., Irwin, Ian, Canafax, Daniel M.

Volltext

Head and neck osteosarcoma at the University of Washington von Oda, Dolphine, Bavisotto, Linda M., Schmidt, Rodney A., McNutt, Michael, Bruckner, James D., Conrad III, Ernest U., Weymuller Jr, Ernest A.

Volltext

EP-100 + paclitaxel to overcome taxane resistance in patients with recurrent LHRH-receptor expressing ovarian cancer von Nick, Alpa Manchandia, Urban, Renata, Gordinier, Mary E, Leuschner, Carola, Rado, Thomas, Bavisotto, Linda M., Whisnant, John, Coleman, Robert L.

Volltext

Hepatic Transcatheter Arterial Chemoembolization Alternating with Systemic Protracted Continuous Infusion 5-Fluorouracil for Gastrointestinal Malignancies Metastatic to Liver: A Ph... von BAVISOTTO, L. M, PATEL, N. H, ALTHAUS, S. J, COLDWELL, D. M, NGHIEM, H. V, THOMPSON, T, STORER, B, THOMAS, C. R

Volltext

Multicenter Phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG) von Lin, Xuling, Kaley, Thomas Joseph, Pentsova, Elena, DeAngelis, Lisa Marie, Daras, Mariza, Gavrilovic, Igor T., Mellinghoff, Ingo K., McKeown, Andrew, Manne, Malbora, Hansen, Jessica, Bavisotto, Linda M., Gorman, Greg, Lamson, Michael, Karmali, Rashida A., Omuro, Antonio Marcilio Padula

Volltext

CX-01, a Low Anticoagulant Heparin, May Enhance Count Recovery and Treatment Efficacy in Acute Myeloid Leukemia von Kovacsovics, Tibor J., Mims, Alice S., Salama, Mohamed E, Pantin, Jeremy M, Kosak, Ken M, Rao, Narayanam, Ahorukomeye, Peter, Glenn, Martha, Deininger, Michael W., Boucher, Kenneth M, Bavisotto, Linda M, Gutierrez-Sanchez, Gerardo, Kennedy, Thomas P, Marcus, Stephen Garrett, Shami, Paul J

Volltext

O-desulfated heparin and chemotherapy for the treatment of AML von Kovacsovics, Tibor, Mims, Alice S., Salama, Mohamed E., Rao, Narayanam, Pantin, Jeremy, Deininger, Michael W.N., Kennedy, Thomas P, Bavisotto, Linda M., Boucher, Kenneth M., Marcus, Stephen Garrett, Shami, Paul J.

Volltext

Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM) von Omuro, Antonio Marcilio Padula, Beal, Kathryn, McNeill, Katharine Anne, Thomas, Alissa A., Lin, Xuling, Kaley, Thomas Joseph, DeAngelis, Lisa Marie, Mellinghoff, Ingo K., Diamond, Eli L., Chan, Timothy An-thy, Young, Robert J., Yamada, Yoshiya, Gorman, Greg, Lamson, Michael, Bavisotto, Linda M., Karmali, Rashida A.

Volltext

Preliminary Evidence That ODSH (2-O, 3-O Desulfated Heparin) Is Safe and Enhances Count Recovery in Patients Treated with Intensive Therapy for Acute Myeloid Leukemia – Results of... von Kovacsovics, Tibor J., Mims, Alice, Salama, Mohamed E, Pantin, Jeremy M, Deininger, Michael W., Kennedy, Thomas P, Bavisotto, Linda M, Boucher, Kenneth M, Marcus, Stephen G, Shami, Paul J

Volltext

Dose-Response Analyses Of Momelotinib (CYT387), a JAK1 and JAK2 Inhibitor, From a Phase I/II Study (CCL09101) In Treatment Of Myelofibrosis von Xin, Yan, Shao, Lixin, Deng, Wei, Niforos, Demi, Kowalski, Mark, Bavisotto, Linda M, Kawashima, Jun, Jun, Susie, Collins, Helen, Ramanathan, Srinivasan

Volltext

Update On The Long-Term Efficacy and Safety Of Momelotinib, a JAK1 and JAK2 Inhibitor, For The Treatment Of Myelofibrosis von Pardanani, Animesh, Gotlib, Jason, Gupta, Vikas, Roberts, Andrew W., Wadleigh, Martha, Sirhan, Shireen, Bavisotto, Linda M, Kawashima, Jun, Lee, Peter, Kowalski, Mark, Deng, Wei, Niforos, Demi, Tefferi, Ayalew

Volltext

Phase I/II Study of CYT387, a JAK1/JAK2 Inhibitor for the Treatment of Myelofibrosis von Pardanani, Animesh, Gotlib, Jason, Gupta, Vikas, Roberts, Andrew W., Wadleigh, Martha, Sirhan, Shireen, Bavisotto, Linda M, Kawashima, Jun, Kowalski, Mark, Tefferi, Ayalew

Volltext

An Expanded Multicenter Phase I/II Study of CYT387, a JAK- 1/2 Inhibitor for the Treatment of Myelofibrosis von Pardanani, Animesh, Gotlib, Jason, Gupta, Vikas, Roberts, Andrew W, Wadleigh, Martha, Sirhan, Shireen, Litzow, Mark R., Hogan, William J, Begna, Kebede, Smith, Gregg, Bavisotto, Linda M, Kowalski, Mark, Tefferi, Ayalew

Volltext

Modulation of Ca 2+ ‐dependent intercellular adhesion in bovine aortic and human umbilical vein endothelial cells by heparin‐binding growth factors von Bavisotto, Linda M., Schwartz, Stephen M., Heimark, Ronald L.

Volltext

Modulation of Ca2+-dependent intercellular adhesion in bovine aortic and human umbilical vein endothelial cells by heparin-binding growth factors von Bavisotto, Linda M., Schwartz, Stephen M., Heimark, Ronald L.

Volltext

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas von Omuro, Antonio, Beal, Kathryn, McNeill, Katharine, Young, Robert J, Thomas, Alissa, Lin, Xuling, Terziev, Robert, Kaley, Thomas J, DeAngelis, Lisa M, Daras, Mariza, Gavrilovic, Igor T, Mellinghoff, Ingo, Diamond, Eli L, McKeown, Andrew, Manne, Malbora, Caterfino, Andrew, Patel, Krishna, Bavisotto, Linda, Gorman, Greg, Lamson, Michael, Gutin, Philip, Tabar, Viviane, Chakravarty, Debyani, Chan, Timothy A, Brennan, Cameron W, Garrett-Mayer, Elizabeth, Karmali, Rashida A, Pentsova, Elena

Volltext